Proteome of Mouse Oocytes at Different Developmental Stages
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice
Loyola University Chicago Loyola eCommons Biology: Faculty Publications and Other Works Faculty Publications 2013 Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice Mihaela Palicev Gunter P. Wagner James P. Noonan Benedikt Hallgrimsson James M. Cheverud Loyola University Chicago, [email protected] Follow this and additional works at: https://ecommons.luc.edu/biology_facpubs Part of the Biology Commons Recommended Citation Palicev, M, GP Wagner, JP Noonan, B Hallgrimsson, and JM Cheverud. "Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice." Genome Biology and Evolution 5(10), 2013. This Article is brought to you for free and open access by the Faculty Publications at Loyola eCommons. It has been accepted for inclusion in Biology: Faculty Publications and Other Works by an authorized administrator of Loyola eCommons. For more information, please contact [email protected]. This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License. © Palicev et al., 2013. GBE Genomic Correlates of Relationship QTL Involved in Fore- versus Hind Limb Divergence in Mice Mihaela Pavlicev1,2,*, Gu¨ nter P. Wagner3, James P. Noonan4, Benedikt Hallgrı´msson5,and James M. Cheverud6 1Konrad Lorenz Institute for Evolution and Cognition Research, Altenberg, Austria 2Department of Pediatrics, Cincinnati Children‘s Hospital Medical Center, Cincinnati, Ohio 3Yale Systems Biology Institute and Department of Ecology and Evolutionary Biology, Yale University 4Department of Genetics, Yale University School of Medicine 5Department of Cell Biology and Anatomy, The McCaig Institute for Bone and Joint Health and the Alberta Children’s Hospital Research Institute for Child and Maternal Health, University of Calgary, Calgary, Canada 6Department of Anatomy and Neurobiology, Washington University *Corresponding author: E-mail: [email protected]. -
Gene-Set Libraries from Chip-X Experiments to Decode the Transcription Regulome Yan Kou, Edward Chen, Neil Clark, Qiaonan Duan, Christopher Tan, Avi Ma‘Ayan
ChEA2: Gene-Set Libraries from ChIP-X Experiments to Decode the Transcription Regulome Yan Kou, Edward Chen, Neil Clark, Qiaonan Duan, Christopher Tan, Avi Ma‘ayan To cite this version: Yan Kou, Edward Chen, Neil Clark, Qiaonan Duan, Christopher Tan, et al.. ChEA2: Gene-Set Libraries from ChIP-X Experiments to Decode the Transcription Regulome. 1st Cross-Domain Con- ference and Workshop on Availability, Reliability, and Security in Information Systems (CD-ARES), Sep 2013, Regensburg, Germany. pp.416-430. hal-01506771 HAL Id: hal-01506771 https://hal.inria.fr/hal-01506771 Submitted on 12 Apr 2017 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License ChEA2: Gene-Set Libraries from ChIP-X Experiments to Decode the Transcription Regulome Yan Kou1, Edward Y. Chen1, Neil R. Clark1, Qiaonan Duan1, Christopher M. Tan1, Avi Ma‘ayan1,* 1Department of Pharmacology and Systems Therapeutics, Systems Biology Center New York (SBCNY), Icahn School of Medicine at Mount Sinai, New York, NY 10029 * To whom correspondence should be addressed: avi.maayan[at]mssm.edu Abstract. ChIP-seq experiments provide a plethora of data regarding transcription regulation in mammalian cells. -
TAF15 Is Important for Cellular Proliferation and Regulates the Expression of a Subset of Cell Cycle Genes Through Mirnas
Oncogene (2013) 32, 4646–4655 & 2013 Macmillan Publishers Limited All rights reserved 0950-9232/13 www.nature.com/onc ORIGINAL ARTICLE TAF15 is important for cellular proliferation and regulates the expression of a subset of cell cycle genes through miRNAs M Ballarino1, L Jobert1,4, D Dembe´le´ 1, P de la Grange2, D Auboeuf3 and L Tora1 TAF15 (formerly TAFII68) is a member of the FET (FUS, EWS, TAF15) family of RNA- and DNA-binding proteins whose genes are frequently translocated in sarcomas. By performing global gene expression profiling, we found that TAF15 knockdown affects the expression of a large subset of genes, of which a significant percentage is involved in cell cycle and cell death. In agreement, TAF15 depletion had a growth-inhibitory effect and resulted in increased apoptosis. Among the TAF15-regulated genes, targets of microRNAs (miRNAs) generated from the onco-miR-17 locus were overrepresented, with CDKN1A/p21 being the top miRNAs- targeted gene. Interestingly, the levels of onco-miR-17 locus coded miRNAs (miR-17-5p and miR-20a) were decreased upon TAF15 depletion and shown to affect the post-transcriptional regulation of TAF15-dependent genes, such as CDKN1A/p21. Thus, our results demonstrate that TAF15 is required to regulate gene expression of cell cycle regulatory genes post-transcriptionally through a pathway involving miRNAs. The findings that high TAF15 levels are needed for rapid cellular proliferation and that endogenous TAF15 levels decrease during differentiation strongly suggest that TAF15 is a key regulator of maintaining a highly proliferative rate of cellular homeostasis. Oncogene (2013) 32, 4646–4655; doi:10.1038/onc.2012.490; published online 5 November 2012 Keywords: FUS/EWS/TAF15 (FET) proteins; miRNAs; transcription; proliferation; neuronal differentiation; neuroblastoma INTRODUCTION possible role of TAF15 in additional steps of RNA metabolism. -
Dual Functions of TAF7L in Adipocyte Differentiation
RESEARCH ARTICLE elife.elifesciences.org Dual functions of TAF7L in adipocyte differentiation Haiying Zhou1,2, Tommy Kaplan3,4, Yan Li5, Ivan Grubisic2,6, Zhengjian Zhang5, P Jeremy Wang7, Michael B Eisen1,3, Robert Tjian1,2* 1Department of Molecular and Cell Biology, Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, United States; 2Li Ka Shing Center For Biomedical and Health Sciences, CIRM Center of Excellence, University of California, Berkeley, Berkeley, United States; 3Department of Molecular and Cell Biology, California Institute of Quantitative Biosciences, University of California, Berkeley, Berkeley, United States; 4School of Computer Science and Engineering, The Hebrew University of Jerusalem, Jerusalem, Israel; 5Janelia Farm Research Campus, Howard Hughes Medical Institute, Ashburn, United States; 6UC Berkeley-UCSF Graduate Program in Bioengineering, Department of Molecular and Cell Biology, California Institute of Quantitative Biosciences, University of California, Berkeley, Berkeley, United States; 7Department of Animal Biology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, United States Abstract The diverse transcriptional mechanisms governing cellular differentiation and development of mammalian tissue remains poorly understood. Here we report that TAF7L, a paralogue of TFIID subunit TAF7, is enriched in adipocytes and white fat tissue (WAT) in mouse. Depletion of TAF7L reduced adipocyte-specific gene expression, compromised adipocyte differentiation, and WAT development as well. Ectopic expression of TAF7L in myoblasts reprograms these muscle precursors into adipocytes upon induction. Genome-wide mRNA-seq expression profiling and ChIP-seq binding studies confirmed that TAF7L is required for activating adipocyte-specific genes via a dual mechanism wherein it interacts with PPARγ at enhancers and TBP/Pol II at core promoters. -
Crystal Structure of a TAF1-TAF7 Complex in Human Transcription Factor IID Reveals a Promoter Binding Module
Cell Research (2014) 24:1433-1444. npg © 2014 IBCB, SIBS, CAS All rights reserved 1001-0602/14 $ 32.00 ORIGINAL ARTICLE www.nature.com/cr Crystal structure of a TAF1-TAF7 complex in human transcription factor IID reveals a promoter binding module Hui Wang1, 2, Elizabeth C Curran1, Thomas R Hinds1, 2, Edith H Wang1, Ning Zheng1, 2 1Department of Pharmacology, 2Howard Hughes Medical Institute, Box 357280, University of Washington, Seattle, WA 98195, USA The general transcription factor IID (TFIID) initiates RNA polymerase II-mediated eukaryotic transcription by nucleating pre-initiation complex formation at the core promoter of protein-encoding genes. TAF1, the largest in- tegral subunit of TFIID, contains an evolutionarily conserved yet poorly characterized central core domain, whose specific mutation disrupts cell proliferation in the temperature-sensitive mutant hamster cell line ts13. Although the impaired TAF1 function in the ts13 mutant has been associated with defective transcriptional regulation of cell cycle genes, the mechanism by which TAF1 mediates transcription as part of TFIID remains unclear. Here, we present the crystal structure of the human TAF1 central core domain in complex with another conserved TFIID subunit, TAF7, which biochemically solubilizes TAF1. The TAF1-TAF7 complex displays an inter-digitated compact architecture, featuring an unexpected TAF1 winged helix (WH) domain mounted on top of a heterodimeric triple barrel. The single TAF1 residue altered in the ts13 mutant is buried at the junction of these two structural domains. We show that the TAF1 WH domain has intrinsic DNA-binding activity, which depends on characteristic residues that are commonly used by WH fold proteins for interacting with DNA. -
RNA Binding Protein TAF15 Suppresses Toxicity in a Yeast Model of FUS Proteinopathy
RNA Binding Protein TAF15 Suppresses Toxicity in a Yeast Model of FUS Proteinopathy Elliott Hayden Wright State University Aicha Kebe Wright State University Shuzhen Chen Wright State University Abagail Chumley Wright State University Chenyi Xia Shanghai University of Traditional Chinese Medicine Quan Zhong Wright State University Shulin Ju ( [email protected] ) Wright State University Research Article Keywords: FUS, RNA binding protein, ALS, toxicity Posted Date: April 22nd, 2021 DOI: https://doi.org/10.21203/rs.3.rs-437201/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License RNA binding protein TAF15 suppresses toxicity in a yeast model of FUS proteinopathy Elliott Hayden1, Aicha Kebe1, Shuzhen Chen1, Abagail Chumley1, Chenyi Xia2, Quan Zhong1* and Shulin Ju1* 1Department of Biological Sciences, Wright State University, Dayton, OH 45435 2School of Basic Medicine, Shanghai University of Traditional Medicine, Shanghai, China 201203 *Corresponding authors: [email protected]; [email protected] Abstract Mutations in Fused in Sarcoma (FUS), an RNA binding protein that functions in multiple steps in gene expression regulation and RNA processing, are known to cause familial amyotrophic lateral sclerosis (ALS). Since this discovery, mutations in several other RNA binding proteins (RBPs) have also been linked to ALS. Some of these ALS-associated RBPs have been shown to colocalize with ribonucleoprotein (RNP) granules such as stress granules and processing bodies (p-bodies). Characterization of ALS-associated proteins, their mis-localization, aggregation and toxicity in cellular and animal models have provided critical insights in disease. More and more evidence has emerged supporting a hypothesis that impaired clearance, inappropriate assembly, and dysregulation of RNP granules play a role in ALS. -
FUS ALS-Causative Mutations Impact FUS Autoregulation and the Processing of RNA-Binding Proteins Through Intron Retention
bioRxiv preprint doi: https://doi.org/10.1101/567735; this version posted March 4, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Humphrey et al. FUS ALS-causative mutations impact FUS autoregulation and the processing of RNA-binding proteins through intron retention 1,2,3# 1 2 2 1 Jack Humphrey , Nicol Birsa , Carmelo Milioto , David Robaldo , Matthew Bentham , 1,3 1 4 1,2,5 4,6 Seth Jarvis , Cristian Bodo , Maria Giovanna Garone , Anny Devoy , Alessandro Rosa , 4,6 1 2,5 1,7 Irene Bozzoni , Elizabeth Fisher , Marc-David Ruepp , Giampietro Schiavo , Adrian 1,2 3 1 Isaacs , Vincent Plagnol , Pietro Fratta 1. UCL Queen Square Institute of Neurology, University College London, London WC1E 6BT, UK. 2. UK Dementia Research Institute, London, UK 3. UCL Genetics Institute, University College London, London WC1E 6BT, UK. 4. Sapienza University of Rome, Rome, IT. 5. Maurice Wohl Clinical Neuroscience Institute, King’s College London, London, UK. 6. Center for Life Nano Science, Istituto Italiano di Tecnologia, Rome, IT. 7. Discoveries Centre for Regenerative and Precision Medicine, University College London Campus, London WC1N 3BG, UK. #. Current address: Ronald M. Loeb Center for Alzheimer’s Disease, Department of Neuroscience and Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10129, USA. Key words: FUS, autoregulation, ALS, intron retention Correspondence: [email protected]; [email protected] Abstract Mutations in the RNA binding protein FUS cause amyotrophic lateral sclerosis (ALS), a devastating neurodegenerative disease in which the loss of motor neurons induces progressive weakness and death from respiratory failure, typically only 3-5 years after onset. -
Non-Canonical TAF Complexes Regulate Active Promoters in Human Embryonic Stem Cells
University of Massachusetts Medical School eScholarship@UMMS Program in Gene Function and Expression Publications and Presentations Molecular, Cell and Cancer Biology 2012-11-13 Non-canonical TAF complexes regulate active promoters in human embryonic stem cells Glenn A. Maston University of Massachusetts Medical School Et al. Let us know how access to this document benefits ou.y Follow this and additional works at: https://escholarship.umassmed.edu/pgfe_pp Part of the Genetics and Genomics Commons Repository Citation Maston GA, Zhu LJ, Chamberlain L, Lin L, Fang M, Green MR. (2012). Non-canonical TAF complexes regulate active promoters in human embryonic stem cells. Program in Gene Function and Expression Publications and Presentations. https://doi.org/10.7554/eLife.00068. Retrieved from https://escholarship.umassmed.edu/pgfe_pp/211 This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in Program in Gene Function and Expression Publications and Presentations by an authorized administrator of eScholarship@UMMS. For more information, please contact [email protected]. RESEARCH ARTICLE elife.elifesciences.org Non-canonical TAF complexes regulate active promoters in human embryonic stem cells Glenn A Maston1,2, Lihua Julie Zhu1,3, Lynn Chamberlain1,2, Ling Lin1,2, Minggang Fang1,2, Michael R Green1,2* 1Programs in Gene Function and Expression and Molecular Medicine, University of Massachusetts Medical School, Worcester, United States; 2Howard Hughes Medical Institute, Chevy Chase, United States; 3Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, United States Abstract The general transcription factor TFIID comprises the TATA-box-binding protein (TBP) and approximately 14 TBP-associated factors (TAFs). -
Structures of Three Distinct Activator–TFIID Complexes
Downloaded from genesdev.cshlp.org on October 1, 2021 - Published by Cold Spring Harbor Laboratory Press Structures of three distinct activator–TFIID complexes Wei-Li Liu,1 Robert A. Coleman,1 Elizabeth Ma,1 Patricia Grob,2 Joyce L. Yang,1 Yixi Zhang,1 Gina Dailey,1 Eva Nogales,2 and Robert Tjian1,3 1Howard Hughes Medical Institute, Molecular and Cell Biology Department, University of California at Berkeley, Berkeley, California 94720, USA; 2Howard Hughes Medical Institute, Molecular and Cell Biology Department, University of California at Berkeley and Lawrence Berkeley National Laboratory, Berkeley, California 94720, USA Sequence-specific DNA-binding activators, key regulators of gene expression, stimulate transcription in part by targeting the core promoter recognition TFIID complex and aiding in its recruitment to promoter DNA. Although it has been established that activators can interact with multiple components of TFIID, it is unknown whether common or distinct surfaces within TFIID are targeted by activators and what changes if any in the structure of TFIID may occur upon binding activators. As a first step toward structurally dissecting activator/TFIID interactions, we determined the three-dimensional structures of TFIID bound to three distinct activators (i.e., the tumor suppressor p53 protein, glutamine-rich Sp1 and the oncoprotein c-Jun) and compared their structures as determined by electron microscopy and single-particle reconstruction. By a combination of EM and biochemical mapping analysis, our results uncover distinct contact regions within TFIID bound by each activator. Unlike the coactivator CRSP/Mediator complex that undergoes drastic and global structural changes upon activator binding, instead, a rather confined set of local conserved structural changes were observed when each activator binds holo- TFIID. -
Granulocyte Colony-Stimulating Factor-Induced TAF9 Modulates P53-TRIAP1-CASP3 Axis to Prevent Retinal Ganglion Cell Death After Optic Nerve Ischemia
Granulocyte Colony-Stimulating Factor-Induced TAF9 Modulates P53-TRIAP1-CASP3 Axis to Prevent Retinal Ganglion Cell Death after Optic Nerve Ischemia Yao-Tseng Wen Buddhist Tzu Chi General Hospital Hualien: Hualien Tzu Chi Hospital Keh-Liang Lin Chung Shan Medical University Hospital Chin-Te Huang Tzu Chi University Rong Kung Tsai ( [email protected] ) Hualien Tzu Chi Hospital https://orcid.org/0000-0001-8760-5739 Research article Keywords: Granulocyte colony-stimulating factor, Rat anterior ischemic optic neuropathy model, Retinal ganglion cell, TBP associated factor 9, TP53, TRIAP1 Posted Date: January 6th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-138908/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/25 Abstract Background Optic nerve head (ONH) infarct can result in progressive retinal ganglion cell (RGC) death. Some evidences indicated that the granulocyte colony-stimulating factor (GCSF) provides positive effects against ischemic damage on RGCs. However, protective mechanisms of the GCSF after ONH infarct are complex and remain unclear. Methods To investigate the complex mechanisms, the transcriptome proles of the GCSF-treated retinas were examined using microarray technology. The retinal mRNA samples on days 3 and 7 post rat anterior ischemic optic neuropathy model (rAION) were analyzed by microarray and bioinformatics analyses. To evaluate the TAF9 function in RGC apoptosis, GCSF plus TAF9 siRNA-treated rats were evaluated using retrograde labeling with FluoroGold assay, TUNEL assay, and Western blotting in a rAION. Results GCSF treatment inuenced 3101 genes and 3332 genes on days 3 and 7 post rAION, respectively. -
Interplay of RNA-Binding Proteins and Micrornas in Neurodegenerative Diseases
International Journal of Molecular Sciences Review Interplay of RNA-Binding Proteins and microRNAs in Neurodegenerative Diseases Chisato Kinoshita 1,* , Noriko Kubota 1,2 and Koji Aoyama 1,* 1 Department of Pharmacology, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi, Tokyo 173-8605, Japan; [email protected] 2 Teikyo University Support Center for Women Physicians and Researchers, 2-11-1 Kaga, Itabashi, Tokyo 173-8605, Japan * Correspondence: [email protected] (C.K.); [email protected] (K.A.); Tel.: +81-3-3964-3794 (C.K.); +81-3-3964-3793 (K.A.) Abstract: The number of patients with neurodegenerative diseases (NDs) is increasing, along with the growing number of older adults. This escalation threatens to create a medical and social crisis. NDs include a large spectrum of heterogeneous and multifactorial pathologies, such as amyotrophic lateral sclerosis, frontotemporal dementia, Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and multiple system atrophy, and the formation of inclusion bodies resulting from protein misfolding and aggregation is a hallmark of these disorders. The proteinaceous components of the pathological inclusions include several RNA-binding proteins (RBPs), which play important roles in splicing, stability, transcription and translation. In addition, RBPs were shown to play a critical role in regulating miRNA biogenesis and metabolism. The dysfunction of both RBPs and miRNAs is Citation: Kinoshita, C.; Kubota, N.; often observed in several NDs. Thus, the data about the interplay among RBPs and miRNAs and Aoyama, K. Interplay of RNA-Binding Proteins and their cooperation in brain functions would be important to know for better understanding NDs and microRNAs in Neurodegenerative the development of effective therapeutics. -
TAF15 Antibody Cat
TAF15 Antibody Cat. No.: 27-294 TAF15 Antibody Specifications HOST SPECIES: Rabbit SPECIES REACTIVITY: Human Antibody produced in rabbits immunized with a synthetic peptide corresponding a region IMMUNOGEN: of human TAF15. TESTED APPLICATIONS: ELISA, WB TAF15 antibody can be used for detection of TAF15 by ELISA at 1:312500. TAF15 antibody APPLICATIONS: can be used for detection of TAF15 by western blot at 3.0 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50,000 - 100,000. POSITIVE CONTROL: 1) Cat. No. 1211 - HepG2 Cell Lysate PREDICTED MOLECULAR 62 kDa WEIGHT: Properties PURIFICATION: Antibody is purified by protein A chromatography method. CLONALITY: Polyclonal CONJUGATE: Unconjugated PHYSICAL STATE: Liquid September 25, 2021 1 https://www.prosci-inc.com/taf15-antibody-27-294.html Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% BUFFER: sucrose. CONCENTRATION: batch dependent For short periods of storage (days) store at 4˚C. For longer periods of storage, store TAF15 STORAGE CONDITIONS: antibody at -20˚C. As with any antibody avoid repeat freeze-thaw cycles. Additional Info OFFICIAL SYMBOL: TAF15 ALTERNATE NAMES: TAF15, Npl3, RBP56, TAF2N, TAFII68 ACCESSION NO.: NP_631961 PROTEIN GI NO.: 21327701 GENE ID: 8148 USER NOTE: Optimal dilutions for each application to be determined by the researcher. Background and References Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals.